283 related articles for article (PubMed ID: 35915501)
21. Prevention programs for chronic kidney disease in low-income countries.
Perico N; Remuzzi G
Intern Emerg Med; 2016 Apr; 11(3):385-9. PubMed ID: 26983956
[TBL] [Abstract][Full Text] [Related]
22. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
Otieno FCF; Ogola EN; Kimando MW; Mutai K
BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
[TBL] [Abstract][Full Text] [Related]
23. External validation of a minimal-resource model to predict reduced estimated glomerular filtration rate in people with type 2 diabetes without diagnosis of chronic kidney disease in Mexico: a comparison between country-level and regional performance.
Sammut-Powell C; Sisk R; Silva-Tinoco R; de la Pena G; Almeda-Valdes P; Juarez Comboni SC; Goncalves S; Cameron R
Front Endocrinol (Lausanne); 2024; 15():1253492. PubMed ID: 38586458
[TBL] [Abstract][Full Text] [Related]
24. Review article: Early detection of chronic kidney disease in Australia: which way to go?
Mathew T; Corso O
Nephrology (Carlton); 2009 Jun; 14(4):367-73. PubMed ID: 19563377
[TBL] [Abstract][Full Text] [Related]
25. The importance of early identification of chronic kidney disease.
Whaley-Connell A; Nistala R; Chaudhary K
Mo Med; 2011; 108(1):25-8. PubMed ID: 21462606
[TBL] [Abstract][Full Text] [Related]
26. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.
Okpechi IG; Caskey FJ; Gaipov A; Tannor EK; Hamonic LN; Ashuntantang G; Donner JA; Figueiredo A; Inagi R; Madero M; Malik C; Moorthy M; Pecoits-Filho R; Tesar V; Levin A; Jha V
BMJ Open; 2021 Dec; 11(12):e053857. PubMed ID: 34916325
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.
Reilly R; Evans K; Gomersall J; Gorham G; Peters MD; Warren S; O'Shea R; Cass A; Brown A
BMC Health Serv Res; 2016 Apr; 16():119. PubMed ID: 27048280
[TBL] [Abstract][Full Text] [Related]
28. Urbanization and kidney function decline in low and middle income countries.
Jagannathan R; Patzer RE
BMC Nephrol; 2017 Aug; 18(1):276. PubMed ID: 28851306
[TBL] [Abstract][Full Text] [Related]
29. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
30. Chronic kidney disease in low- and middle-income countries.
Stanifer JW; Muiru A; Jafar TH; Patel UD
Nephrol Dial Transplant; 2016 Jun; 31(6):868-74. PubMed ID: 27217391
[TBL] [Abstract][Full Text] [Related]
31. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025.
Kainz A; Hronsky M; Stel VS; Jager KJ; Geroldinger A; Dunkler D; Heinze G; Tripepi G; Oberbauer R
Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv113-8. PubMed ID: 26209733
[TBL] [Abstract][Full Text] [Related]
32. Global perspective of kidney diseases: Challenges and changes.
Nangaku M
Nephrology (Carlton); 2023 Aug; 28 Suppl 1():5-7. PubMed ID: 37534846
[TBL] [Abstract][Full Text] [Related]
33. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
Okeah BO; Ridyard CH
Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
[TBL] [Abstract][Full Text] [Related]
35. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
Heo NJ; Rhee SY; Waalen J; Steinhubl S
Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
[TBL] [Abstract][Full Text] [Related]
36. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease : A mixed-methods study.
Lopez-Vargas PA; Tong A; Howell M; Phoon RK; Chadban SJ; Shen Y; Craig JC
Nephrology (Carlton); 2017 May; 22(5):374-381. PubMed ID: 27248507
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China.
Zhou Y; Echouffo-Tcheugui JB; Gu JJ; Ruan XN; Zhao GM; Xu WH; Yang LM; Zhang H; Qiu H; Narayan KM; Sun Q
BMC Nephrol; 2013 Nov; 14():253. PubMed ID: 24238578
[TBL] [Abstract][Full Text] [Related]
38. Chronic kidney disease epidemic: How do we deal with it?
Ng JK; Li PK
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():116-120. PubMed ID: 30298662
[TBL] [Abstract][Full Text] [Related]
39. The impact of kidney foundations in alleviating the burden of CKD in India - an example, Tamilnad Kidney Research Foundation.
Abraham G; Vijayan M; Ravi R; Kumaraswami L; Venkatesan M
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):74-77. PubMed ID: 27469149
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
